The Next Phase: Exploring Innovation in Clinical Trials

Nael Abdelsamad, a physician and director of research at Cleveland Clinic Abu Dhabi, shares his insights on transforming clinical trials through technology. He discusses the shift towards decentralized clinical trials in the post-pandemic era, highlighting both their potential and the challenges of integration. Nael emphasizes the importance of harnessing AI and machine learning to enhance patient experiences while minimizing administrative burdens. He also addresses the need for streamlined tech solutions and workforce development to foster a more efficient trial landscape.

Rick Malone, former president of the McCreadie Group and now Business Development Director at Inovalon, shares insights on innovating clinical trials. He discusses the vital role of collaboration among pharma companies and research sites for standardization. Malone highlights challenges like staffing shortages and the push for interoperability across platforms. He dives into how data integration and automation can streamline trials, enhance patient experiences, and ultimately lead to a more efficient research landscape.

Gordon Harris, Co-founder and Chief Science Officer at Yunu, leverages his expertise in medical imaging to discuss revolutionary advancements in clinical trials. He explores how technology can streamline processes, enhance global site connectivity, and improve patient access to trials. The conversation highlights the importance of interoperability and innovative platforms in addressing industry challenges. Harris also emphasizes the concept of 'naive optimism' in driving positive change and fostering creative collaboration in clinical trial innovation.

With an industry that is based on data and numbers, it's important to stay ahead of the game. It's what you do in the present that will redeem the past and thereby change the future.For this episode, we’re joined by Mazhar Jaffry, a physician doctor with extensive experience in the marketing sales business development, and is the founder and CEO of Revival Research Institute, LLC. Dr. Jaffry talks about his journey with a rich history of experience and his aim to take the organization to the top of the industry in the coming years, with ambitious goals to revolutionize clinical trials. He shares all the big innovations and challenges that are coming, because to embrace the future of healthcare we must accept its ever-evolving changes.Join us as we discuss:Dr. Jaffry’s passion for learning and educating peopleRevival Research Institute's growth, focus, and goalsData management, diversity, patient retention, and other challenges facing clinical trialsThe need for a very strong network and the importance of partnershipBig innovations in patient care and processes Impact of COVID-19 in the evolution of the industry

The only way to drive innovation and improve the efficiency of the sector is to create alliances and be collaborative; to be able to do more together than separately with patient-centered objectives.In this episode, we discuss the challenges and innovations that are transforming the landscape of drug development and clinical trials, and how we can grow in a market with so many players. Carlos Orantes, CEO of Alconza Clinical Research, shares his insights from over 30 years of experience in the industry, and dives into the importance of collaboration and teamwork to address all the industry challenges, emphasizing on the main objective: An approach centered on the patient.Join us as we discuss:How innovation in technology is playing an important role in streamlining processes and the positive impact on patient care, experience, participation and diversityInsights and advice for the future of clinical trials, focusing on the impact of the patients and sites while removing barriers and finding opportunities around the worldThe role of FDA guidelines in driving innovation, particularly in diversity and decentralizationThe significance of continuous learning and mentorship in staying innovative

Matt Smith, VP of Research Site Development at Slope, dives into the cutting-edge world of clinical trials. He discusses the critical shift to digital processes and how technology can streamline research for sponsors and sites. With a focus on efficiency and interoperability, Matt highlights the role of AI in transforming operations. He also emphasizes the importance of collaboration among research sites, sponsors, and vendors to enhance experiences and reduce risks in trials. Join the exploration of innovation and its practical impacts!

Sandy Smith, Senior VP of Clinical Solutions at WCG, shares her journey from advanced practice nurse to a leader in clinical research. She discusses the critical link between clinical care and research, especially in oncology. Sandy highlights the complexities of modern trials shaped by technology and resource challenges. She emphasizes patient-specific data to streamline trial timelines and envisions the transformative role of AI in recruitment and site identification. Collaborations and diverse experiences are key for advancing the future of clinical trials.

Accreditation and standardization are the keys to driving positive change in the clinical research industry, leaving a lasting legacy and making strides toward global collaboration.Today we’re joined by Jacqueline Johnson North, CEO and Co-Founder of GCSA. The Global Clinical Site Assessment Standard enables clinical research sites, CROs, and sponsors to work synergistically, while fostering a truly patient-centric system. We discuss the development of a certification standard for clinical research sites, the 7-module approach of their assessment, and the impact on the industry. Join as we discuss:The role of GCSA in overcoming barriers and building a patient-centric systemThe value of certification standards in driving positive change in the industryThe need for collaboration and innovation to improve the efficiency and effectiveness of clinical research

Dave Hine, Senior Director of Sales Engineering at Greenphire, shares his unique transition from aerospace engineering to clinical trials. He discusses the vital role of patient-centricity and technology in enhancing enrollment and patient experiences. Hine emphasizes the importance of clear communication and user engagement for successful technology adoption. He also envisions future innovations, including targeted treatments and aviation simulation techniques for budgeting in clinical research, offering invaluable advice for newcomers to the industry.

Melisa Tucker, Head of Research Evidence Generation Program at Verily, brings her expertise in healthcare innovation to the table. She shares her vision for a unified source of healthcare data to enhance patient care and transform clinical research. The conversation highlights the growing receptiveness of the healthcare industry to technology, the potential of AI and unstructured data, and the importance of collaboration for career growth. Melisa emphasizes the need for an infrastructure that supports both research and improved healthcare delivery.